Does Abstinence From E-cigarettes Produce Withdrawal Symptoms?
NCT ID: NCT02825459
Last Updated: 2018-11-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
147 participants
INTERVENTIONAL
2016-07-31
2018-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of the Electronic Cigarette on Withdrawal Symptoms
NCT01454362
Evaluation of the Electronic Cigarette Withdrawal Syndrome
NCT06066996
The Effects of Menthol as Delivered by an Electronic Cigarette on the Desirability of Nicotine in Tobacco Users
NCT02102100
Study of Smoking Abstinence
NCT01035632
Effects of Electronic Cigarette Settings and Liquid Concentrations in Cigarette Smokers and Electronic Cigarette Users
NCT03710590
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Every day during the study, participants will report e-cigarette and tobacco cigarette use and monitor symptoms of nicotine withdrawal via a phone call to an Interactive Voice Response system. Participants will attend 3 study visits each week to provide urine and breath samples to verify compliance, and to complete brief surveys.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Abstinence from e-cigarettes
Participants abstain from e-cigarettes and other nicotine/tobacco products for 6 days
Abstinence from e-cigarettes
Abrupt cessation for 6 days
E-cigarette use
Participants use e-cigarettes and continue to abstain from tobacco/nicotine products as they normally would.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Abstinence from e-cigarettes
Abrupt cessation for 6 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to read and understand verbal English fluently
* US citizen or resident alien
* Primarily uses e-cigarette product types of refillable tanks or modified devices
* Uses nicotine-containing e-liquid
* Has baseline urinary cotinine concentration of \> 100 ng/ml
* Has used e-cigarettes daily for the last 2 months
* Has a home or cell phone
* Agrees to abstain from tobacco, marijuana and other illegal drugs during study
Exclusion Criteria
* Used non-cigarette nicotine, tobacco or quit smoking products on \>5 days in the past month
* Use of cannabis (either marijuana or synthetic cannabis) \> 5 times in the past month or positive test for cannabis use at screening
* Current (last 6 months) Generalized Anxiety Disorder, Major Depressive Disorder, Attention Deficit Hyperactivity Disorder or moderate/severe Substance Abuse Disorder
* Multiple legal, social health, work or school problems in the past month due to alcohol or drug use
* Pregnant or breastfeeding
* Previously a participant in the current study
* Use of prescribed or non-prescribed psychoactive medication \> 5 times in the past month
* Expired carbon monoxide level \> 8ppm
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
University of Vermont
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
John Hughes
Faculty, Department of Psychiatry
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John R Hughes, MD
Role: PRINCIPAL_INVESTIGATOR
University of Vermont
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Battelle Memorial Institute
Baltimore, Maryland, United States
University of Vermont
Burlington, Vermont, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hughes JR, Peters EN, Callas PW, Peasley-Miklus C, Oga E, Etter JF, Morley N. Withdrawal Symptoms From E-Cigarette Abstinence Among Adult Never-Smokers: A Pilot Experimental Study. Nicotine Tob Res. 2020 Apr 21;22(5):740-746. doi: 10.1093/ntr/ntz169.
Hughes JR, Peters EN, Callas PW, Peasley-Miklus C, Oga E, Etter JF, Morley N. Withdrawal Symptoms From E-Cigarette Abstinence Among Former Smokers: A Pre-Post Clinical Trial. Nicotine Tob Res. 2020 Apr 21;22(5):734-739. doi: 10.1093/ntr/ntz129.
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.